Clinical trials are carefully designed research studies where volunteers collaborate with researchers to test new ways to understand, prevent, detect, or treat diseases. These studies evaluate the safety and effectiveness of new approaches, such as new drugs, medical devices, medical products, and diagnostic tests, on human subjects.

Each clinical trial follows a detailed protocol that defines how the study will be conducted. This protocol must be reviewed and approved by an Institutional Review Board (IRB) to ensure the study is ethical and that participants are protected.

In the United States, if the study involves a new drug, the sponsor must submit an Investigational New Drug (IND) application to the FDA. The FDA reviews this application and allows the trial to proceed if there are no safety concerns, rather than directly approving the study protocol itself.

Clinical trials are often associated with testing new medicines, but they go beyond that. Researchers may also study medical devices, surgical procedures, or lifestyle interventions such as diet and exercise, all aimed at improving health outcomes and answering important medical questions.

The Purpose

Clinical trials transform innovative ideas into real-world medical solutions. They provide the data needed to:

• Ensure a treatment’s safety and effectiveness.

• Compare new treatments to current standards of care.

• Understand potential risks, side effects, and possible benefits.

• Identify how treatments work for specific conditions.

These studies are integral to the drug approval process, offering critical evidence for regulatory agencies to decide if treatments should become available to a large number of patients.

In practical terms, this is what allows new treatments to move from research into real patient care.

Why Participate?

Participation in clinical trials can offer access to new approaches and contribute to medical research.

For some patients, especially when standard treatments are no longer effective, clinical trials may represent an additional option to explore.

Healthy volunteers also play an important role by helping researchers better understand how treatments work and supporting the development of new therapies.

While participation involves potential risks, every trial is carefully reviewed by an IRB to ensure it is conducted ethically and safely.

Understanding both the potential benefits and risks is key before deciding whether participation makes sense for your situation.

To explore common reasons why patients consider clinical trials, you can read Why Participate in Clinical Research.

Different Types

Clinical trials fall into two main categories: interventional and observational studies.

Understanding the difference between these two types can help you identify which kind of study may be more relevant to you.

Interventional Clinical Trials

Interventional trials actively test the impact of specific experimental treatments, procedures, or preventative measures. Participants are divided into groups, with one group receiving the intervention (e.g., a new drug or medical device) and the other group (called the control group) receiving a standard treatment or a placebo.

These trials are conducted in phases, from small-group Phase 1 trials to large-group Phase 3 trials, ensuring a thorough evaluation of safety and efficacy. Learn more about clinical trial phases.

Types of interventional studies can include:

• Treatment Trials: Assess the safety and effectiveness of new therapies.

• Prevention Trials: Explore ways to prevent diseases or stop them from recurring.

• Diagnostic Trials: Develop more accurate and earlier diagnostic methods.

• Quality of Life Trials: Improve care and comfort for people with chronic conditions.

Observational Clinical Trials

Observational trials (also called clinical research or studies) do not involve specific treatments or interventions. Instead, researchers monitor participants over time, collecting data on health outcomes, risk factors, and disease progression.

These studies are essential for answering research questions, understanding the natural history of diseases, and optimizing existing treatments.

Steps Before Clinical Trials

Before reaching clinical trials, potential treatments undergo a rigorous drug development process to ensure they are safe and promising:

• Drug Discovery: Scientists screen thousands of compounds to identify candidates.

• Preclinical Testing: The most promising compounds are tested in labs and animals.

• IND Submission: Researchers submit an Investigational New Drug (IND) application to regulatory agencies, outlining safety data and trial protocols.

• Clinical Trials: After approval, the treatment progresses through Phase 1, 2, and 3 trials to assess safety, efficacy, and side effects.

• NDA Submission: A New Drug Application (NDA) is submitted for regulatory approval.

This stringent process ensures that only the safest and most effective experimental treatments make it to patients.

In Brief

Clinical trials are the cornerstone of medical progress, bridging the gap between laboratory research and real-world patient care. They enable researchers to translate groundbreaking discoveries into treatments that improve lives and set new standards in healthcare.

Understanding clinical trials is key to appreciating how new therapies, medical devices, and diagnostic tools become available. Whether you’re a potential participant or a curious reader, clinical trials play a vital role in shaping the future of medicine.

At PatLynk, we’re committed to providing reliable information about clinical trials. Explore our platform to learn how these studies improve care and drive innovation.

Start your pre-screening with PatLynk.